Study Name:
Apixaban for the treatment of venous thromboembolism in patients with cancer: a prospective randomized open blinded-endpoint (CARAVAGGIO study)

Phase:
Phase 3b Trial

EudraCT number:
2016-003093-40

National Investigator Coordinator:
Doctor Maria Rosales

Participating countries:
United Kingdom, Belgique, France, Italy, The Netherlands, Germany, Polone, Israel, Spain, Portugal

Sites in Portugal:
IPO Porto, IPO Lisboa, Centro Hospitalar Lisboa Norte -Hospital de Santa Maria, Centro Hospitalar Trás os Montes e Alto Douro

Sponsor:
Fondazione FADOI, Milan, Italy

Status:
Recruitment